Novel Phenolic Compounds as Potential Dual EGFR and COX-2 Inhibitors: Design, Semisynthesis, in vitro Biological Evaluation and in silico Insights

References

• LeeKW, KimYJ, LeeHJ, LeeCY. Cocoa has more phenolic phytochemicals and a higher antioxidant capacity than teas and red wine. J Agric Food Chem. 2003;51:7292–7295. doi:10.1021/jf034438514640573
   PubMed Web of Science ®Google Scholar
• HabauzitV, HorcajadaM-N. Phenolic phytochemicals and bone. Phytochem Rev. 2008;7(2):313–344. doi:10.1007/s11101-007-9078-9
   Google Scholar
• Al‐SaikhanM, HowardL, MillerJJ. Antioxidant activity and total phenolics in different genotypes of potato (Solanum tuberosum, l.). J Food Sci. 1995;60:341–343. doi:10.1111/j.1365-2621.1995.tb05668.x
   Web of Science ®Google Scholar
• IzliG. Total phenolics, antioxidant capacity, colour and drying characteristics of date fruit dried with different methods. Food Sci Technol. 2017;37:139–147. doi:10.1590/1678-457x.14516
   Web of Science ®Google Scholar
• JiangF, DustingGJ. Natural phenolic compounds as cardiovascular therapeutics: potential role of their antiinflammatory effects. Curr Vasc Pharmacol. 2003;1:135–156. doi:10.2174/157016103347673615320840
   PubMedGoogle Scholar
• AbdallahHM, EsmatA. Antioxidant and anti-inflammatory activities of the major phenolics from zygophyllum simplex l. J Ethnopharmacol. 2017;205:51–56. doi:10.1016/j.jep.2017.04.02228465252
   PubMed Web of Science ®Google Scholar
• NohynekLJ, AlakomiH-L, KähkönenMP, et al. Berry phenolics: antimicrobial properties and mechanisms of action against severe human pathogens. Nutr Cancer. 2006;54:18–32. doi:10.1207/s15327914nc5401_416800770
   PubMed Web of Science ®Google Scholar
• ZacchinoSA, ButassiE, Di LibertoM, RaimondiM, PostigoA, SortinoM. Plant phenolics and terpenoids as adjuvants of antibacterial and antifungal drugs. Phytomedicine. 2017;37:27–48.29174958
   PubMed Web of Science ®Google Scholar
• VinayagamR, JayachandranM, XuB. Antidiabetic effects of simple phenolic acids: a comprehensive review. Phytother Res. 2016;30:184–199. doi:10.1002/ptr.552826634804
   PubMed Web of Science ®Google Scholar
• GomesCA, Girão da CruzT, AndradeJL, MilhazesN, BorgesF, MarquesMPM. Anticancer activity of phenolic acids of natural or synthetic origin:  a Structure−Activity Study. J Med Chem. 2003;46(25):5395–5401. doi:10.1021/jm030956v14640548
   PubMed Web of Science ®Google Scholar
• XuM, RaoJ, ChenB. Phenolic compounds in germinated cereal and pulse seeds: classification, transformation, and metabolic process. Crit Rev Food Sci Nutr. 2020;60(5):740–759. doi:10.1080/10408398.2018.155005130633553
   PubMed Web of Science ®Google Scholar
• GhoneimMM, MusaA, El-HelaAA, ElokelyKM. Evaluation and understanding the molecular basis of the antimethicillin-resistant staphylococcus aureus activity of secondary metabolites isolated from lamium amplexicaule. Pharmacogn Mag. 2018;14(55):3. doi:10.4103/pm.pm_541_1729576693
   PubMed Web of Science ®Google Scholar
• MahmoudBK, HamedAN, SamyMN, et al. Phytochemical composition and antimicrobial properties of markhamia platycalyx (baker) sprague leaf. Trop J Pharm Res. 2019;18:2623–2631.
   Web of Science ®Google Scholar
• ZhangJ, YangPL, GrayNS. Targeting cancer with small molecule kinase inhibitors. Nat Rev Cancer. 2009;9(1):28–39. doi:10.1038/nrc255919104514
   PubMed Web of Science ®Google Scholar
• KannaiyanR, MahadevanD. A comprehensive review of protein kinase inhibitors for cancer therapy. Expert Rev Anticancer Ther. 2018;18(12):1249–1270. doi:10.1080/14737140.2018.152768830259761
   PubMed Web of Science ®Google Scholar
• ShenF-Q, WangZ-C, WuS-Y, et al. Synthesis of novel hybrids of pyrazole and coumarin as dual inhibitors of cox-2 and 5-lox. Bioorg Med Chem Lett. 2017;27(16):3653–3660. doi:10.1016/j.bmcl.2017.07.02028720504
   PubMed Web of Science ®Google Scholar
• AbdelgawadMA, BakrRB, AhmadW, Al-SaneaMM, ElshemyHAH. New pyrimidine-benzoxazole/benzimidazole hybrids: synthesis, antioxidant, cytotoxic activity, in vitro cyclooxygenase and phospholipase a2-v inhibition. Bioorg Chem. 2019;92:103218. doi:10.1016/j.bioorg.2019.10321831536956
   PubMed Web of Science ®Google Scholar
• AlkahtaniHM, AbdallaAN, ObaidullahAJ, et al. Synthesis, cytotoxic evaluation, and molecular docking studies of novel quinazoline derivatives with benzenesulfonamide and anilide tails: dual inhibitors of egfr/her2. Bioorg Chem. 2020;95:103461. doi:10.1016/j.bioorg.2019.10346131838290
   PubMed Web of Science ®Google Scholar
• MusaA, Al-muaikelNS, Abdel-BakkyMS. Phytochemical and pharmacological evaluations of ethanolic extract of bassia eriophora. Der Pharma Chem. 2016;8:169–178.
   Google Scholar
• MusaA. Chemical constituents, antimicrobial and antiinflammatory evaluations of various extracts ofsuaeda vera forssk. Growing in Saudi Arabia. Int J Pharm Res. 2019;11:962–967.
   Google Scholar
• Saldaña-RiveraL, BelloM, Méndez-LunaD. Structural insight into the binding mechanism of ATP to EGFR and L858R, and T790M and L858R/T790 mutants. J Biomol Struct Dyn. 2019;37(17):4671–4684. doi:10.1080/07391102.2018.155811230558477
   PubMed Web of Science ®Google Scholar
• BelloM, Saldaña-RiveroL, Correa-BasurtoJ, GarcíaB, Sánchez-EspinosaVA. Structural and energetic basis for the molecular recognition of dual synthetic vs. Natural inhibitors of egfr/her2. Int J Biol Macromol. 2018;111:569–586. doi:10.1016/j.ijbiomac.2017.12.16229329808
   PubMed Web of Science ®Google Scholar
• El-SayedNA, NourMS, SalemMA, ArafaRK. New oxadiazoles with selective-cox-2 and egfr dual inhibitory activity: design, synthesis, cytotoxicity evaluation and in silico studies. Eur J Med Chem. 2019;183:111693. doi:10.1016/j.ejmech.2019.11169331539778
   PubMed Web of Science ®Google Scholar
• AbdelgawadMA, BakrRB, AlkhojaOA, MohamedWR. Design, synthesis and antitumor activity of novel pyrazolo [3, 4-d] pyrimidine derivatives as egfr-tk inhibitors. Bioorg Chem. 2016;66:88–96. doi:10.1016/j.bioorg.2016.03.01127043178
   PubMed Web of Science ®Google Scholar
• ArakiK, HashimotoK, ArdyantoTD, et al. Co-expression of cox-2 and egfr in stage i human bronchial adenocarcinomas. Lung Cancer. 2004;45(2):161–169. doi:10.1016/j.lungcan.2004.01.01315246187
   PubMed Web of Science ®Google Scholar
• YoussifBG, AbdelrahmanMH, AbdelazeemAH, et al. Design, synthesis, mechanistic and histopathological studies of small-molecules of novel indole-2-carboxamides and pyrazino [1, 2-a] indol-1 (2h)-ones as potential anticancer agents effecting the reactive oxygen species production. Eur J Med Chem. 2018;146:260–273. doi:10.1016/j.ejmech.2018.01.04229407956
   PubMed Web of Science ®Google Scholar
• ShawkyAM, AbourehabMA, AbdallaAN, GoudaAM. Optimization of pyrrolizine-based schiff bases with 4-thiazolidinone motif: design, synthesis and investigation of cytotoxicity and anti-inflammatory potency. Eur J Med Chem. 2020;185:111780. doi:10.1016/j.ejmech.2019.11178031655429
   PubMed Web of Science ®Google Scholar
• BenelliR, VenèR, MinghelliS, CarloneS, GatteschiB, FerrariN. Celecoxib induces proliferation and amphiregulin production in colon subepithelial myofibroblasts, activating erk1–2 signaling in synergy with egfr. Cancer Lett. 2013;328:73–82. doi:10.1016/j.canlet.2012.09.00823010081
   PubMed Web of Science ®Google Scholar
• AbdelgawadMA, AbdellatifKR, AhmedOM. Design, synthesis and anticancer screening of novel pyrazole derivatives linking to benzimidazole, benzoxazole and benzothiazole. Med Chem S. 2014;1:2161–2444.
   Google Scholar
• AbdelgawadMA, BakrRB, El-GendyAO, KamelGM, AzouzAA, BukhariSNA. Discovery of a cox-2 selective inhibitor hit with anti-inflammatory activity and gastric ulcer protective effect. Future Med Chem. 2017;9:1899–1912. doi:10.4155/fmc-2017-011529076755
   PubMed Web of Science ®Google Scholar
• AbdelgawadMA, BelalA, AhmedOM. Synthesis, molecular docking studies and cytotoxic screening of certain novel thiazolidinone derivatives substituted with benzothiazole or benzoxazole. J Chem Pharm Res. 2013;5:318–327.
   Google Scholar
• AbdelgawadMA, MohamedAM, MusaA, MostafaEM, AwadHM. Synthesis, chromatographic separation and antimicrobial evolution of new azoquinoline-8-ol. J Pharm Sci Res. 2018;10:1314–1318.
   Google Scholar
• GaoX, KuoJ, JiangH, et al. Immunomodulatory activity of curcumin: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production in vitro. Biochem Pharmacol. 2004;68:51–61. doi:10.1016/j.bcp.2004.03.01515183117
   PubMed Web of Science ®Google Scholar
• GaoX, XuYX, JanakiramanN, ChapmanRA, GautamSC. Immunomodulatory activity of resveratrol: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production. Biochem Pharmacol. 2001;62:1299–1308. doi:10.1016/S0006-2952(01)00775-411705464
   PubMed Web of Science ®Google Scholar
• Al-SaneaMM. Synthesis and biological evaluation of small molecule modulators of cdk8/cyclin c complex with phenylaminoquinoline scaffold. PeerJ. 2020;8:e8649. doi:10.7717/peerj.864932206448
   PubMed Web of Science ®Google Scholar
• Al-SaneaM, AbdelazemA, ParkB, et al. Ros1 kinase inhibitors for molecular-targeted therapies. Curr Med Chem. 2016;23:142–160. doi:10.2174/092986732266615100609362326438251
   PubMed Web of Science ®Google Scholar
• PohankaM, HrabinovaM, KucaK. Diagnosis of intoxication by the organophosphate vx: comparison between an electrochemical sensor and ellman´ s photometric method. Sensors. 2008;8:5229–5237. doi:10.3390/s809522927873811
   PubMed Web of Science ®Google Scholar
• AhmadW, KumolosasiE, JantanI, BukhariSN, JasamaiM. Effects of novel diarylpentanoid analogues of curcumin on secretory phospholipase a2, cyclooxygenases, lipo‐oxygenase, and microsomal prostaglandin e synthase‐1. Chem Biol Drug Des. 2014;83:670–681. doi:10.1111/cbdd.1228024406103
   PubMed Web of Science ®Google Scholar
• BukhariSNA, LauroG, JantanI, BifulcoG, AmjadMW. Pharmacological evaluation and docking studies of α, β-unsaturated carbonyl based synthetic compounds as inhibitors of secretory phospholipase a2, cyclooxygenases, lipoxygenase and proinflammatory cytokines. Bioorg Med Chem. 2014;22:4151–4161. doi:10.1016/j.bmc.2014.05.05224938495
   PubMed Web of Science ®Google Scholar
• JantanI, BukhariSNA, AdekoyaOA, SylteI. Studies of synthetic chalcone derivatives as potential inhibitors of secretory phospholipase a2, cyclooxygenases, lipoxygenase and pro-inflammatory cytokines. Drug Des Devel Ther. 2014;8:1405. doi:10.2147/DDDT.S67370
   PubMed Web of Science ®Google Scholar
• GogosCA, DrosouE, BassarisHP, SkoutelisA. Pro-versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis. 2000;181:176–180. doi:10.1086/31521410608764
   PubMed Web of Science ®Google Scholar
• Al-SaneaMM, ElkamhawyA, PaikS, et al. Sulfonamide-based 4-anilinoquinoline derivatives as novel dual aurora kinase (aurka/b) inhibitors: synthesis, biological evaluation and in silico insights. Bioorg Med Chem. 2020;28:115525. doi:10.1016/j.bmc.2020.11552532371117
   PubMed Web of Science ®Google Scholar
• Al‐SaneaMM, ParkBS, AbdelazemAZ, et al. Optimization of bipyridinyl pyrazole scaffolds via design, synthesis and screening of a new series of ros1 kinase‐modulating compounds. Bull Korean Chem Soc. 2015;36:305–311. doi:10.1002/bkcs.10077
   Web of Science ®Google Scholar
• KaurA, PathakDP, SharmaV, WakodeS. Synthesis, biological evaluation and docking study of a new series of di-substituted benzoxazole derivatives as selective cox-2 inhibitors and anti-inflammatory agents. Bioorg Med Chem. 2018;26:891–902. doi:10.1016/j.bmc.2018.01.00729373271
   PubMed Web of Science ®Google Scholar
• MostafaEM, GamalM, GhoneimMM, et al. Repurposing of FDA approved alkaloids as covid 19 inhibitors; in silico studies. Pharmacogn J. 2021;13.
   Google Scholar
• AlkhaldiAA, MusaA, MostafaEM, AminE, De KoningHP. Docking studies and antiprotozoal activity of secondary metabolites isolated from scrophularia syriaca benth. Growing in Saudi Arabia. Rec Nat Prod. 2020;14:30.
   Google Scholar